Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.39 |
| ▸ | FABP7 | O15540 | 2/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.37 |
| ▸ | MDM4 | O15151 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16060617 | 1.00 | KMT2A (0.42) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL28124396 | 0.97 | KMT2A (0.43) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL17079656 | 0.97 | KMT2A (0.43) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL16061106 | 0.96 | KMT2A (0.45) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL28124397 | 0.96 | KMT2A (0.45) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL5973232 | 0.93 | KMT2A (0.41) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL29173690 | 0.93 | KMT2A (0.41) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL16061070 | 0.89 | KMT2A (0.39) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL28035104 | 0.89 | KMT2A (0.39) | KMT2AFABP5FABP7MDM2MDM4 | |
| SCHEMBL30983360 | 0.88 | KMT2A (0.38) | KMT2AFABP5FABP7MDM2MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117343142-A | Leucine and lysine-rich high-efficiency low-toxicity anti-tumor peptide and application thereof | 兰州大学 | 2024-01-05 | — | — | CN | disclosed |
| CN-106456574-A | Hybrid immunoglobulins containing non-peptide linkages | 丹尼尔·J·卡鹏 | 2017-02-22 | — | — | CN | disclosed |